Effect of disease activity and corticosteroids on serum levels of soluble endothelial cell protein C receptor in patients with systemic lupus erythematosus

References

• Fukudome K, Esmon CT. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem. 1994;269:26486–91.
   PubMed Web of Science ®Google Scholar
• Regan LM, Stearns-Kurosawa DJ, Kurosawa S, Mollica J, Fukudome K, Esmon CT. The endothelial cell protein C receptor: inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors. J Biol Chem. 1996;271:17499–503.
   PubMed Web of Science ®Google Scholar
• Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin—thrombomodulin complex. Proc Natl Acad Sci USA. 1996;93:10212–6.
   Google Scholar
• Kurosawa S, Stearns-Kurosawa DJ, Hidari N, Esmon CT. Iden-tification of functional endothelial protein C receptor in human plasma. J Clin Invest. 1997;100:411–8.
   PubMed Web of Science ®Google Scholar
• Stearns-Kurosawa DJ, Swindle K, D'Angelo A, Della VP, Fattorini A, Caron N, et al. Plasma levels of endothelial protein C receptor respond to anticoagulant treatment. Blood. 2002;99:526–30.
   Google Scholar
• Morelli S, Bernardo M, Viganego F, Sgreccia A, De Marzio P, Conti F, et al. Left sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus. Lupus. 2003;12:805–12.
   PubMed Web of Science ®Google Scholar
• Bessant R, Hingorani A, Patel L, MacGregor A, Isenberg DA, Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology. 2004;43:924–9.
   PubMed Web of Science ®Google Scholar
• Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol. 1997;145:408–15.
   Google Scholar
• Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2399–406.
   PubMed Web of Science ®Google Scholar
• Nacach AZ, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 2000;43:1801–8.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum. 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients (The Committee on Prognosis Studies in SLE). Arthritis Rheum. 1992;35:630–40.
   PubMed Web of Science ®Google Scholar
• Klippel JH. Criteria for the classification and diagnosis of the rheumatic diseases. In: Klippel JH, Crofford LJ, Stone JH, Weyand CM, editors. Primer on rheumatic diseases. 12th ed. Atlanta: Arthritis Foundation; 2001:727–42.
   Google Scholar
• Boffa MC, Karmochkine M. 'Thrombomodulin: an overview and potential implications in vascular disorders. Lupus. 1998;7:120–5.
   PubMed Web of Science ®Google Scholar
• Boehme MWJ, Raeth U, Galle PR, Stremmel W, Scherbaum WA. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity. Clin Exp Immunol. 2000;119:189–95.
   Google Scholar
• Kotajima L, Aotsuka S, Sato T. Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic dis-eases. Clin Exp Rheumatol. 1997;15:59–65.
   Google Scholar
• Witte T, Hartung K, Sachse C, Fricke M, Buyny S, Deicher H, et al. Thrombomodulin in systemic lupus erythematosus: asso-ciation with clinical and laboratory parameters. Rheumatol Int. 1999;19:15–8.
   PubMed Web of Science ®Google Scholar
• Ho CY, Wong CK, Li EK, Tam LS, Lam CW. Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and sol-uble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2003;42: 117–22.
   Google Scholar
• Laszik Z, Mitro A, Taylor FB Jr, Ferrell G, Esmon CT. Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation. 1997;96:3633–40.
   Google Scholar
• Isermann B, Sood R, Pawlinski R, Zogg M, Kanoway S, Degen JL, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med. 2003;9:331–7.
   PubMed Web of Science ®Google Scholar
• Oganesyan V, Oganesyan N, Terzyan S, Qu D, Dauter Z, Esmon NL, etal. The crystal structure of the endothelial protein C receptor and a bound phospholipid. J Biol Chem. 2002;277:24851–4.
   Google Scholar
• Sesin CA, Yin X, Esmon CT, Buyon JP, Clancy RM. Shedding of endothelial protein C receptor contributes to vasculopathy and renal injury in lupus: in vivo and in vitro evidence. Kidney Int. 2005;68:407–8.
   Google Scholar
• Calvo-Alen J, Toloza SM, Fernandez M, Bastian HM, Fessler BJ, Roseman JM, et al. LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum. 2005;52:2060–8.
   Google Scholar
• Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, Gandrille S. A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood. 2004;103:1311–8.
   PubMed Web of Science ®Google Scholar
• Nagasawa K, Ishii Y, Mayumi T, Tada Y, Ueda A, Yamauchi Y, et al. Avascular necrosis of bone in systemic lupus erythemato-sus: possible role of haemostatic abnormalities. Ann Rheum Dis. 1989;48:672–6.
   PubMed Web of Science ®Google Scholar